Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

Lauren O’Connor, MS, RDN, is a health and lifestyle writer and five-time cookbook author based in Los Angeles. She is a registered dietitian with over 15 years of experience in the field, specializing ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

Out are the days of only slogging through grueling high-intensity workouts like CrossFit and bootcamp classes day after day. Nowadays, chiller, low-impact activities, like walking, are having a moment ...

Eating enough to build muscle while still keeping body fat in check can be a challenge for anyone who wants to feel stronger, fitter, and more confident without obsessing over calories. For many women ...

Auditory illusions, like how a word begins to sound meaningless when repeated, offer clues into the structure of language.

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...

NeuroPace, Inc. ( NPCE) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Good afternoon, and welcome to NeuroPace Fourth Quarter 2025 Conference Call. As a reminder, this call is being recorded.

Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...

Australians living with autoimmune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access to new medicines thanks to ...

ImmunityBio has successfully established two major international distribution partnerships within days, significantly expanding the global reach of its bladder cancer immunotherapy, ANKTIVA. These ...